Back to company

MACURE PHARMA ApS: Financial statements 2023

CVR: 35234748

MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 24,158,862 and a net result of DKK 8,790,375 compared with DKK 17,894,545 the year before. That is a decrease of 35.6% compared with the year before. Equity amounted to DKK 14,184,632. The solvency ratio was 8.3%. The company had 13 employees in the financial year.

Gross Profit
24,158,862 kr.
Profit/Loss
8,790,375 kr.
Equity
14,184,632 kr.
Total Assets
170,273,323 kr.
Employees
13

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-24.2 mio.8.8 mio.14.2 mio.13
2022-37.5 mio.17.9 mio.23.4 mio.10
2021-25 mio.5 mio.10.5 mio.6
2020-15.1 mio.5.3 mio.10.5 mio.10
2019-16.3 mio.9.2 mio.14.2 mio.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

MACURE PHARMA ApS appoints new auditorNov 16, 2023

As of November 16, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MACURE PHARMA ApS.

Auditor steps down at MACURE PHARMA ApSNov 16, 2023

As of November 16, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MACURE PHARMA ApS.

MACURE PHARMA ApS: The 2022 annual report is outJul 6, 2023

MACURE PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 37,526,784, and the net result was DKK 17,894,545.

About MACURE PHARMA ApS

MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity amounted to DKK 18,033,649.